Research analysts at William Blair lowered their Q2 2026 earnings estimates for J.Jill in a report released on Thursday, ...

Stock analysts at William Blair issued their FY2026 earnings per share estimates for shares of LENZ Therapeutics in a ...

Fintel reports that on March 21, 2025, William Blair downgraded their outlook for Valmont Industries (NYSE:VMI) from ...

Software company DocuSign’s (DOCU) stock scored a rating upgrade from Hold to Buy from William Blair, thanks to the optimism ...

As Klarna wins installment lending for the retail giant's OnePay app, rival Affirm seeks to downplay the loss.

William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process is strengthened by low costs across its parent firm's funds, whose fees rank in their respective ...

The embedded finance company, which posted a loss last year, hired Citigroup to explore its strategic options and named an ...

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The main contributor to the rating is the stability of the management team. Specifically, the fund has not seen a ...

William Blair analyst Matthew Phipps last night upgraded Genmab (GMAB) to Outperform from Market Perform without a price target. after the ...

The note emphasized that Palantir shares declined 10% following a 4% selloff in the Nasdaq, and if the broader market ...